@article{6214b3897c604980876c3433d9c9596e,
title = "Concurrent and adjuvant temozolomide-based chemoradiotherapy schedules for glioblastoma. Hypotheses based on two prospective phase II trials",
abstract = "To investigate the impact of nonstandard concomitant temozolomide (TMZ) administration in two prospective phase II studies for glioblastoma (GBM).",
keywords = "Adult, Aged, Aged, 80 and over, Antineoplastic Agents, Alkylating, Brain Neoplasms, Chemoradiotherapy, Adjuvant, Clinical Trials, Phase II as Topic, Combined Modality Therapy, Dacarbazine, Disease-Free Survival, Glioblastoma, Humans, Italy, Middle Aged, Prevalence, Prospective Studies, Risk Assessment, Survival Rate, Treatment Outcome, Young Adult, Adult, Aged, Aged, 80 and over, Antineoplastic Agents, Alkylating, Brain Neoplasms, Chemoradiotherapy, Adjuvant, Clinical Trials, Phase II as Topic, Combined Modality Therapy, Dacarbazine, Disease-Free Survival, Glioblastoma, Humans, Italy, Middle Aged, Prevalence, Prospective Studies, Risk Assessment, Survival Rate, Treatment Outcome, Young Adult",
author = "Mario Balducci and A. Fiorentino and Alba Fiorentino and {De Bonis}, Pasquale and Silvia Chiesa and Annunziato Mangiola and Mattiucci, {Gian Carlo} and D'Agostino, {Giuseppe Roberto} and Vincenzo Frascino and Giovanna Mantini and Alitto, {Anna Rita} and Cesare Colosimo and Carmelo Anile and Vincenzo Valentini",
year = "2013",
doi = "10.1007/s00066-013-0410-6",
language = "English",
volume = "189",
pages = "926--931",
journal = "Strahlentherapie und Onkologie",
issn = "0179-7158",
publisher = "Urban und Vogel",
}